Cambrex Competitors, Revenue, Alternatives and Pricing

Claim your profile


East Rutherford, NJ USA
Total Funding:N/A
Lead Investor(s):JPMorgan Chase Bank N.A

State Ranking

Estimated Revenue & Financials

  • Cambrex's estimated annual revenue is currently $531M per year.
  • Cambrex received $200.0M in venture funding in April 2007.
  • Cambrex's estimated revenue per employee is $507,163

Employee Data

  • Cambrex has 1047 Employees.
  • Cambrex grew their employee count by 38% last year.
  • Cambrex currently has 34 job openings.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingOnline ReviewPricing
Missing a competitor? Contribute!?

Cambrex is an innovative life sciences company with a refreshingly human approach. Driven by passion, our pharmaceutical products, expertise and technologies accelerate our customers small molecule therapeutics into markets across the world. With over 35 years of active pharmaceutical ingredient (API) development and manufacturing expertise, a growing team of more than 1,200 experts and a strong presence in the USA and Europe, we are tried and trusted across branded and generic API markets. > We put all of our energy and experience into being your partner of choice > We create value for customers through manufacturing excellence, reliable quality and innovative science > Our people are the experts that our customers enjoy working with Our custom development and manufacturing capabilities include enzymatic biotransformations, high potency APIs, high energy chemical synthesis and controlled substances. We are committed to operating our facilities with the highest standards for regulatory, environmental, health, safety, and security guidelines. We actively incorporate Lean Six Sigma to consistently deliver efficient, high quality, and cost competitive products with less time to market for our clients. We are proud of our long history of regulatory excellence. When you work with Cambrex, you can expect a friendly, energetic and customer-focused team that will deliver your project requirements. And theyll do so with passion and integrity at the core. To experience the Cambrex difference, get in touch.



Number of Employees


Revenue (est)


Current Jobs


Employee Growth %


Total Funding







Cambrex News

09/06/2019 - Form PREM14A CAMBREX CORP For: Sep 05

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

08/12/2019 - SHAREHOLDER UPDATE: Brodsky & Smith, LLC Announces ...

Under the terms of the transaction, Cambrex shareholders will receive only $60.00 in cash each share of Cambrex stock they own.

08/13/2019 - CAMBREX INVESTOR ALERT By the Former Attorney ...

CAMBREX INVESTOR ALERT By the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and ...

Cambrex Funding

DateAmountRoundLead InvestorsReference
2001-11-30$430.0MCredit FacilityArticle
2004-08-03$0.0MTitle: President CEOArticle
2007-04-09$200.0MUndisclosedJPMorgan Chase Bank N.AArticle

Cambrex Executive Hires

2002-04-09Aaron HeifetzVP, GC & Site DirArticle
2003-03-07Gary L. MossmanPres Pharma Biz UnitArticle
2003-11-20Gary MossmanCEO/Pres Biopharma Biz UnitArticle
2005-05-10David DeMarcoVice President Strategic PlanningArticle
2005-10-03Shawn P. CavanaghSVPArticle
2005-11-08David DeMarcoVP Strategy/Corp DevArticle
2006-01-05James A. MackActing Pres/CEOArticle
2007-02-12Steven M. KloskEVP/COOArticle
2008-05-16Steven M. KloskPresident/CEOArticle
2008-05-16John R. MillerChairmanArticle
2011-01-10Shawn CavanaghSVP/COOArticle
2015-02-03Samantha M HanleyVP General Counsel/SecretaryArticle
2017-01-06Tom VadakethEVP/CFOArticle

Cambrex Acquisitions

DateCompany NameAmountNotesReference
2016-09-27PharmaCore, Inc.Article
2018-11-21Avista Pharma SolutionsArticle

Cambrex Hiring Plans

DateNumber of EmployeesLocationReference